Trial Profile
The Effects of Dexmedetomidine and Tracheal Intubation on Heart Rate Variability and QTc Interval
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Pain
- Focus Pharmacodynamics
- 25 Feb 2019 Status changed from recruiting to completed.
- 04 Dec 2013 Planned number of patients changed from 60 to 66 as reported by ClinicalTrials.gov.
- 04 Dec 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.